These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11825099)

  • 1. Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?
    Henderson DC
    CNS Drugs; 2002; 16(2):77-89. PubMed ID: 11825099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S
    Curr Pharm Des; 2004; 10(18):2219-29. PubMed ID: 15281897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
    Henderson DC; Cagliero E; Copeland PM; Louie PM; Borba CP; Fan X; Freudenreich O; Goff DC
    J Clin Psychiatry; 2007 Apr; 68(4):533-41. PubMed ID: 17474808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Schizophrenia, diabetes mellitus and antipsychotics].
    Gury C
    Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
    Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
    Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature.
    Muench J; Carey M
    J Am Board Fam Pract; 2001; 14(4):278-82. PubMed ID: 11458971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal glucose metabolism in patients treated with antipsychotics.
    Scheen AJ; De Hert MA
    Diabetes Metab; 2007 Jun; 33(3):169-75. PubMed ID: 17412628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics and hyperglycaemia.
    Mir S; Taylor D
    Int Clin Psychopharmacol; 2001 Mar; 16(2):63-73. PubMed ID: 11236071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset diabetes and ketoacidosis with atypical antipsychotics.
    Wilson DR; D'Souza L; Sarkar N; Newton M; Hammond C
    Schizophr Res; 2003 Jan; 59(1):1-6. PubMed ID: 12413635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.
    Henderson DC
    Curr Diab Rep; 2002 Apr; 2(2):135-40. PubMed ID: 12643133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.
    Luft B; Taylor D
    Expert Opin Pharmacother; 2006 Sep; 7(13):1739-48. PubMed ID: 16925501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics and diabetes mellitus.
    Schwenkreis P; Assion HJ
    World J Biol Psychiatry; 2004 Apr; 5(2):73-82. PubMed ID: 15179666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
    Vuk A; Kuzman MR; Baretic M; Osvatic MM
    Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.
    Nasrallah HA; Newcomer JW
    J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S7-14. PubMed ID: 15356415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics and glucose dysregulation: a systematic review.
    Jin H; Meyer JM; Jeste DV
    Schizophr Res; 2004 Dec; 71(2-3):195-212. PubMed ID: 15474892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
    Ramaswamy K; Kozma CM; Nasrallah H
    Drug Saf; 2007; 30(7):589-99. PubMed ID: 17604410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antipsychotic drugs. Risk factors for diabetes].
    Stip E; Tranulis C; Légaré N; Poulin MJ
    Presse Med; 2003 Oct; 32(34):1612-7. PubMed ID: 14576587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.